In a systematic review and meta-analysis, the reduction in chronic noncancer pain from opioids versus placebo was significant but small, and...
Is your patient’s nosebleed a self-limiting occurrence, or a sign of something more worrisome? And which treatments are best in which situations...
In this study, significant opioid tapering was achieved following frank discussions and the use of a tapering protocol. And patient-physician...
Expires November 30, 2019 The severe psychiatric and somatic symptoms of PMDD can be debilitating and place women at increased risk for...
SAN DIEGO - Screening offers insight into drug use, says physician who offers series of tips
SAN DIEGO – Evidence isn’t overwhelming, pain specialist says, but cannabis beats opioids on safety.
CHICAGO – First phase 3 results from an OA trial testing a nerve growth factor antibody, tanezumab.
SAN FRANCISCO – Nearly one-quarter were receiving substantial high-dose opioid prescriptions.
The agency’s approval of Dsuvia comes at a time when the need is great for nonaddictive agents for pain control.